Search
Enter keywords, a title or a report id number below.
Your Search for 'Pharmaceutical Manufacturers (Japan) - Portfolio Analysis' returned 129 results - Page 1 of 7
Sort by
Sorted by
Rank
Top-Bottom
-
Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players
GBI Research, Apr 2013 , Pages: 97represents a great deal of opportunity for generic manufacturers. Historically, the Japanese pharmaceutical market has favored domestic companies. However, since the 1990s, deregulation has promoted ... -
Pharmaceutical Packaging Industry - 2011 Yearbook
GBI Research, Dec 2011 , Pages: 76provides insights into the global pharmaceutical packaging market and information on market forecasts until 2017. In addition to this, the geographical distribution of pharmaceutical packaging manufacturers ... -
The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand
GBI Research, Dec 2009 , Pages: 62packaging manufacturers across key geographies such as the US, the top five countries in the European region, and Japan are also provided in the report. Key cost and developmental issues are also addressed ... -
The Top 50 European Manufacturers of Orthopaedic Implants
Research Facts Ltd, Jan 2012 , Pages: 140The Top 50 European Manufacturers of Orthopaedic Implants Did you know? - Approximately 8 out of 10 people experience severe low back pain at least once in their life. - 40% of the population over ... -
The Outlook for Pharmaceuticals in the Middle East and North Africa
Espicom Business Intelligence Ltd, Feb 2012developed countries have been noticeably less keen, GSK-Banaja and the Saudi Arabian Japanese (SAJA) Pharmaceutical Company being notable exceptions. Recent investments include Pfizer’s plans to build a ... -
Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
GBI Research, Dec 2010 , Pages: 177- Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” provides key data, information and analysis of the major trends and issues affecting the Pharmaceutical ... -
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
GBI Research, May 2011 , Pages: 69analyzed in much detail, along with an elaborate company portfolio and strategic analysis of leading generic players. This report is built using data and information sourced from proprietary databases ... -
Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers' Production Capacity May Force Regulatory Bodies to Re-Design Guidelines on Quality Standards
GBI Research, Feb 2011 , Pages: 83M&A, and Licensing Deals 8.7 Mylan 8.7.1 Company Overview 8.7.2 SWOT Analysis 8.7.3 M&A, and licensing Deals 8.8 DSM Pharmaceutical 8.8.1 Company Overview 8.8.2 SWOT Analysis 8.8.3 M&A, and ... -
The Top 25 U.S. Pharmaceutical Manufacturing Companies
Research Facts Ltd, Sep 2011 , Pages: 70The Top 25 U.S. Pharmaceutical Manufacturing Companies Did you know? - Hospira, Inc. is the world leader in specialty generic injectable pharmaceuticals. - Johnson & Johnson’s broad portfolio ... -
The Future of Contract Manufacturing - Market Forecasts to 2015 and Key Trends
GBI Research, Dec 2009 , Pages: 67outsourcing of Pharmaceutical production for Western Pharmaceutical manufacturers to Asian Countries. The global CMO market was valued at $21 billion in 2008. This market grew at around 9.5% over 2007 when the ... -
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs
GBI Research, Dec 2012 , Pages: 78generic drugs market in the US, the top five countries in the European Union (EU, covering the UK, France, Germany, Spain and Italy) and Japan. The report focuses on the detailed analysis of major ... -
Opportunities in Emerging Markets - Latin America, Brazil, and Mexico
Decision Resources, Inc, Jun 2011Emerging Markets AstraZeneca’s Portfolio Approach Sanofi’s Generics and Feet-on-the-Ground Approach Teva Pharmaceutical Industries’ Bolt-On Acquisitions Approach About the Author About the Expert ... -
Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D
GBI Research, Nov 2011 , Pages: 160- Country analysis of regulatory framework, investments, research clusters and overall support including the US, the UK, Germany, France, Japan, China, India, Singapore, Canada, and Australia. - Investment ... -
The Top 50 Distributors Of Dental Surgery & Laboratory Products In Europe
Research Facts Ltd, Mar 2013 , Pages: 135laboratory products in Europe. This unique and comprehensive report identifies and profiles the top 50. These major companies partner with leading manufacturers and sell their products to dentists and dental ... -
Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report
Infiniti Research Limited, Nov 2012 , Pages: 72Expiration on Key Drugs Categories for 2012-2016 - A Survey Report, has been prepared based on responses from over 200 participants across patented drug manufacturers, generic drug manufacturers, and a ... -
U.S. Pharmaceutical Intermediates Markets
Frost & Sullivan, Feb 2004. List of Abbreviations 3. Total U.S. Pharmaceutical Intermediates Market 1. Introduction 1. Market Overview and Definitions 2. Market Engineering Research Measurement Analysis ... -
Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and CRO Outsourcing
Arrowhead Publishers, Apr 2005 , Pages: 213Pharmaceutical R&D includes the following features: - A thorough market analysis of the global pharmaceutical industry, including the challenges faced by pharmaceutical manufacturers and the technological ... -
Minimally Invasive and Non Invasive Product and Service Market (2009–2014)
Markets and Markets, Jul 2009 , Pages: 179. - Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super ... -
Analgesics - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2010 , Pages: 76748 Table 2: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and ... -
Japan Pharmaceuticals and Healthcare Report Q4 2011
Business Monitor International, Aug 2011 , Pages: 109shares of Japan's Taiyo Pharmaceutical Industry for US$934mn in cash. Taiyo is the third largest generic drug manufacturer in Japan, with a portfolio of over 550 products and sales of approximately US ...
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
